Why are the thresholds assay-specific?

High-sensitivity troponin assays from different manufacturers report different absolute numbers for the same patient, so the ESC publishes separate cut-offs for each. Roche hs-cTnT, Abbott hs-cTnI, and Siemens hs-cTnI all have their own rule-in, rule-out, and delta values, which is why you must select the right assay.

What does observe mean?

Observe is the middle zone where neither rule-in nor rule-out criteria are met. These patients need a further troponin measurement, usually at 3 hours, plus ongoing clinical and ECG assessment before a decision can be made.

Is a rule-out enough to discharge?

No. The algorithm rule-out is only valid alongside a non-ischaemic ECG and low clinical risk, and for the very-low single-value pathway, symptom onset more than three hours earlier. The biomarker is one part of a structured pathway, never the whole decision.

What units does this use?

Nanograms per litre, ng/L, which is numerically identical to picograms per millilitre, pg/mL. Make sure your laboratory reports in these units and not in micrograms per litre, which would be a thousand-fold different.

Does a positive troponin always mean a heart attack?

No. Troponin rises in many conditions including myocarditis, pulmonary embolism, sepsis, renal failure, and tachyarrhythmia. A dynamic rise raises the chance of acute myocardial infarction, but the diagnosis still depends on the clinical picture and ECG.

What is the High-Sensitivity Troponin Serial Rise Calculator?

Compares two high-sensitivity troponin values in ng/L against assay-specific ESC 0h/1h and 0h/3h algorithm thresholds for Roche, Abbott, and Siemens platforms, returning a rule-in, rule-out, or observe verdict with the reasoning. Runs in your browser. It runs free in your browser on Gera Tools, with nothing uploaded.

High-Sensitivity Troponin Serial Rise Calculator

Name: High-Sensitivity Troponin Serial Rise Calculator
Creator: Gera Tools
License: https://creativecommons.org/licenses/by/4.0/

High-sensitivity troponin assays let emergency clinicians rule acute coronary syndrome in or out within an hour using a baseline value and a single repeat. The decision hinges on assay-specific thresholds and on the change between the two samples. This calculator applies the published ESC algorithm rules so you can see the verdict and why it was reached.

How it works

The algorithms are deliberately ordered so that rule-in is checked before rule-out for safety. For the 0h/1h pathway the logic is:

rule-in   if baseline >= high  OR  1h delta >= delta_rule-in
rule-out  if baseline < very_low
          OR (baseline < low  AND  1h delta < delta_rule-out)
otherwise observe

The thresholds differ by assay. For Roche hs-cTnT the published values are a very-low of 5, a low of 12, a direct rule-in of 52 ng/L, and one-hour deltas of 3 and 5. Abbott and Siemens assays carry their own numbers, which the tool substitutes when you change the selection. The 0h/3h pathway instead compares both values against the 99th percentile upper reference limit and looks for a significant dynamic change.

Notes and cautions

A rule-out result is only valid with a non-ischaemic ECG and low clinical risk, and the single-sample very-low rule-out assumes symptom onset more than three hours earlier. A rule-in raises the probability of myocardial infarction but does not prove it, because troponin also rises in myocarditis, pulmonary embolism, sepsis, renal failure, and tachyarrhythmia. The cut-offs here are published educational values; always use your own laboratory’s validated thresholds and combine the result with the full clinical assessment.

Understanding the three verdict zones

The ESC algorithms produce three outcomes, each with a distinct clinical implication:

Rule-in signals a high probability of acute myocardial infarction. This is triggered either by a very high baseline value alone (above the high cut-off for the chosen assay) or by a large absolute rise — the delta — between samples. A rule-in should prompt cardiological assessment and further investigation, but the diagnosis requires integration with ECG findings and clinical presentation. Troponin also rises in myocarditis, pulmonary embolism, sepsis, tachyarrhythmia, renal failure, and takotsubo cardiomyopathy, so a positive biomarker alone does not establish ACS.

Rule-out requires either a very low baseline (below the very-low cut-off, implying symptoms must have begun more than three hours earlier) or a combination of a low baseline and a small delta. A safe rule-out also depends on a non-ischaemic ECG and low clinical risk score. In most validated cohorts the negative predictive value of a proper rule-out is very high, but it is not absolute — clinically compelling presentations still require further evaluation regardless of the biomarker result.

Observe is the middle zone where neither criterion is met. This typically means a third sample at three hours is needed, and the patient should remain monitored with serial ECG assessment.

Why the delta matters as much as the absolute value

A single elevated troponin could reflect chronic cardiac disease or a non-ACS cause. It is the dynamic pattern — a rising (or falling) trajectory — that distinguishes acute myocardial injury from a stable elevated baseline. The ESC algorithms formalise this by requiring a minimum absolute change, not just a percentage rise. Using absolute delta values also reduces the risk of false rule-ins in patients with chronically elevated baselines, such as those with renal failure or heart failure.

Choosing the right pathway

Use the 0h/1h pathway when a rapid assessment is needed and the laboratory can reliably return a result within the hour. The 0h/3h pathway is appropriate when the 1h sample is not available or when clinical uncertainty warrants a longer observation window. Some departments use a hybrid approach, moving patients who are neither ruled in nor ruled out at 1h to a 3h endpoint. Both pathways are validated against large registry datasets; use whichever your department’s protocol specifies and always apply your own laboratory’s validated cut-offs, which may differ slightly from the published ESC values shown here.